TARO-BUDESONIDE

Google image searchProduct monograph

Active ingredient

budesonide, 0.25 MG/ML

DIN: 02494272

Dosage form(s): SUSPENSION

Route(s) of administration: INHALATION

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 04-JUN-2021

ATC:

Reference brand drug: Rhinocort

Pharmaceutical standard: MFR

Search on Google

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-budesonide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.